APO Research
Talk to an analyst

APO RESEARCH · REPORT

α-blocker

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global α-blocker Market Analysis and Forecast 2026-2032

21 December 2025194 pages

Choose your research edition.

Industry Researchα-blocker Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal α-blocker Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal α-blocker Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal α-blocker Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal α-blocker Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global α-blocker market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for α-blocker is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for α-blocker is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for α-blocker is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for α-blocker is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of α-blocker include Teva Pharmaceutical, Sanofi, Jhonson and Johnson, Novartis, Merck, Eli Lilly, Pfizer, GSK and Bayer, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for α-blocker, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of α-blocker, also provides the sales of main regions and countries. Of the upcoming market potential for α-blocker, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the α-blocker sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global α-blocker market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for α-blocker sales, projected growth trends, production technology, application and end-user industry.

α-blocker Segment by Company

Teva Pharmaceutical

Sanofi

Jhonson and Johnson

Novartis

Merck

Eli Lilly

Pfizer

GSK

Bayer

Bristol-Myers Squibb

Astra Zeneca

α-blocker Segment by Type

Non-selective Antagonists

Selective Antagonists

α-blocker Segment by Application

Raynaud's Disease

Hypertension

Erectile Dysfunction

α-blocker Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global α-blocker market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of α-blocker and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of α-blocker.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of α-blocker in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of α-blocker manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, α-blocker sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global α-blocker Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Non-selective Antagonists Major Manufacturers Table 3. Selective Antagonists Major Manufacturers Table 4. Global α-blocker Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Raynaud's Disease Major Manufacturers Table 6. Hypertension Major Manufacturers Table 7. Erectile Dysfunction Major Manufacturers Table 8. α-blocker Industry Trends Table 9. α-blocker Industry Drivers Table 10. α-blocker Industry Opportunities and Challenges Table 11. α-blocker Industry Restraints Table 12. Global α-blocker Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global α-blocker Revenue by Region (2021-2026) & (US$ Million) Table 14. Global α-blocker Revenue by Region (2027-2032) & (US$ Million) Table 15. Global α-blocker Revenue Market Share by Region (2021-2026) Table 16. Global α-blocker Revenue Market Share by Region (2027-2032) Table 17. Global α-blocker Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k tons) Table 18. Global α-blocker Sales by Region (2021-2026) & (k tons) Table 19. Global α-blocker Sales by Region (2027-2032) & (k tons) Table 20. Global α-blocker Sales Market Share by Region (2021-2026) Table 21. Global α-blocker Sales Market Share by Region (2027-2032) Table 22. Global α-blocker Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global α-blocker Revenue Market Share by Manufacturers (2021-2026) Table 24. Global α-blocker Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global α-blocker Sales Market Share by Manufacturers (2021-2026) Table 26. Global α-blocker Sales Price (US$/ton) of Manufacturers (2021-2026) Table 27. Global α-blocker Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global α-blocker Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global α-blocker Manufacturers, Product Type & Application Table 30. Global α-blocker Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global α-blocker by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global α-blocker Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global α-blocker Revenue by Type (2021-2026) & (US$ Million) Table 35. Global α-blocker Revenue by Type (2027-2032) & (US$ Million) Table 36. Global α-blocker Revenue Market Share by Type (2021-2026) Table 37. Global α-blocker Revenue Market Share by Type (2027-2032) Table 38. Global α-blocker Sales by Type 2021 VS 2025 VS 2032 (k tons) Table 39. Global α-blocker Sales by Type (2021-2026) & (k tons) Table 40. Global α-blocker Sales by Type (2027-2032) & (k tons) Table 41. Global α-blocker Sales Market Share by Type (2021-2026) Table 42. Global α-blocker Sales Market Share by Type (2027-2032) Table 43. Global α-blocker Price by Type (2021-2026) & (US$/ton) Table 44. Global α-blocker Price by Type (2027-2032) & (US$/ton) Table 45. Global α-blocker Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global α-blocker Revenue by Application (2021-2026) & (US$ Million) Table 47. Global α-blocker Revenue by Application (2027-2032) & (US$ Million) Table 48. Global α-blocker Revenue Market Share by Application (2021-2026) Table 49. Global α-blocker Revenue Market Share by Application (2027-2032) Table 50. Global α-blocker Sales by Application 2021 VS 2025 VS 2032 (k tons) Table 51. Global α-blocker Sales by Application (2021-2026) & (k tons) Table 52. Global α-blocker Sales by Application (2027-2032) & (k tons) Table 53. Global α-blocker Sales Market Share by Application (2021-2026) Table 54. Global α-blocker Sales Market Share by Application (2027-2032) Table 55. Global α-blocker Price by Application (2021-2026) & (US$/ton) Table 56. Global α-blocker Price by Application (2027-2032) & (US$/ton) Table 57. Teva Pharmaceutical Company Information Table 58. Teva Pharmaceutical Business Overview Table 59. Teva Pharmaceutical α-blocker Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 60. Teva Pharmaceutical α-blocker Product Portfolio Table 61. Teva Pharmaceutical Recent Development Table 62. Sanofi Company Information Table 63. Sanofi Business Overview Table 64. Sanofi α-blocker Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 65. Sanofi α-blocker Product Portfolio Table 66. Sanofi Recent Development Table 67. Jhonson and Johnson Company Information Table 68. Jhonson and Johnson Business Overview Table 69. Jhonson and Johnson α-blocker Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 70. Jhonson and Johnson α-blocker Product Portfolio Table 71. Jhonson and Johnson Recent Development Table 72. Novartis Company Information Table 73. Novartis Business Overview Table 74. Novartis α-blocker Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 75. Novartis α-blocker Product Portfolio Table 76. Novartis Recent Development Table 77. Merck Company Information Table 78. Merck Business Overview Table 79. Merck α-blocker Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 80. Merck α-blocker Product Portfolio Table 81. Merck Recent Development Table 82. Eli Lilly Company Information Table 83. Eli Lilly Business Overview Table 84. Eli Lilly α-blocker Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 85. Eli Lilly α-blocker Product Portfolio Table 86. Eli Lilly Recent Development Table 87. Pfizer Company Information Table 88. Pfizer Business Overview Table 89. Pfizer α-blocker Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 90. Pfizer α-blocker Product Portfolio Table 91. Pfizer Recent Development Table 92. GSK Company Information Table 93. GSK Business Overview Table 94. GSK α-blocker Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 95. GSK α-blocker Product Portfolio Table 96. GSK Recent Development Table 97. Bayer Company Information Table 98. Bayer Business Overview Table 99. Bayer α-blocker Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 100. Bayer α-blocker Product Portfolio Table 101. Bayer Recent Development Table 102. Bristol-Myers Squibb Company Information Table 103. Bristol-Myers Squibb Business Overview Table 104. Bristol-Myers Squibb α-blocker Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 105. Bristol-Myers Squibb α-blocker Product Portfolio Table 106. Bristol-Myers Squibb Recent Development Table 107. Astra Zeneca Company Information Table 108. Astra Zeneca Business Overview Table 109. Astra Zeneca α-blocker Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 110. Astra Zeneca α-blocker Product Portfolio Table 111. Astra Zeneca Recent Development Table 112. North America α-blocker Revenue by Type (2021-2026) & (US$ Million) Table 113. North America α-blocker Revenue by Type (2027-2032) & (US$ Million) Table 114. North America α-blocker Sales by Type (2021-2026) & (k tons) Table 115. North America α-blocker Sales by Type (2027-2032) & (k tons) Table 116. North America α-blocker Sales Price by Type (2021-2026) & (US$/ton) Table 117. North America α-blocker Sales Price by Type (2027-2032) & (US$/ton) Table 118. North America α-blocker Revenue by Application (2021-2026) & (US$ Million) Table 119. North America α-blocker Revenue by Application (2027-2032) & (US$ Million) Table 120. North America α-blocker Sales by Application (2021-2026) & (k tons) Table 121. North America α-blocker Sales by Application (2027-2032) & (k tons) Table 122. North America α-blocker Sales Price by Application (2021-2026) & (US$/ton) Table 123. North America α-blocker Sales Price by Application (2027-2032) & (US$/ton) Table 124. North America α-blocker Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. North America α-blocker Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 126. North America α-blocker Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 127. North America α-blocker Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 128. North America α-blocker Sales by Country (2021-2026) & (k tons) Table 129. North America α-blocker Sales by Country (2027-2032) & (k tons) Table 130. North America α-blocker Sales Price by Country (2021-2026) & (US$/ton) Table 131. North America α-blocker Sales Price by Country (2027-2032) & (US$/ton) Table 132. United States α-blocker Revenue (2021-2032) & (US$ Million) Table 133. Canada α-blocker Revenue (2021-2032) & (US$ Million) Table 134. Mexico α-blocker Revenue (2021-2032) & (US$ Million) Table 135. Europe α-blocker Revenue by Type (2021-2026) & (US$ Million) Table 136. Europe α-blocker Revenue by Type (2027-2032) & (US$ Million) Table 137. Europe α-blocker Sales by Type (2021-2026) & (k tons) Table 138. Europe α-blocker Sales by Type (2027-2032) & (k tons) Table 139. Europe α-blocker Sales Price by Type (2021-2026) & (US$/ton) Table 140. Europe α-blocker Sales Price by Type (2027-2032) & (US$/ton) Table 141. Europe α-blocker Revenue by Application (2021-2026) & (US$ Million) Table 142. Europe α-blocker Revenue by Application (2027-2032) & (US$ Million) Table 143. Europe α-blocker Sales by Application (2021-2026) & (k tons) Table 144. Europe α-blocker Sales by Application (2027-2032) & (k tons) Table 145. Europe α-blocker Sales Price by Application (2021-2026) & (US$/ton) Table 146. Europe α-blocker Sales Price by Application (2027-2032) & (US$/ton) Table 147. Europe α-blocker Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. Europe α-blocker Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 149. Europe α-blocker Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 150. Europe α-blocker Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 151. Europe α-blocker Sales by Country (2021-2026) & (k tons) Table 152. Europe α-blocker Sales by Country (2027-2032) & (k tons) Table 153. Europe α-blocker Sales Price by Country (2021-2026) & (US$/ton) Table 154. Europe α-blocker Sales Price by Country (2027-2032) & (US$/ton) Table 155. Germany α-blocker Revenue (2021-2032) & (US$ Million) Table 156. France α-blocker Revenue (2021-2032) & (US$ Million) Table 157. U.K. α-blocker Revenue (2021-2032) & (US$ Million) Table 158. Italy α-blocker Revenue (2021-2032) & (US$ Million) Table 159. Russia α-blocker Revenue (2021-2032) & (US$ Million) Table 160. Spain α-blocker Revenue (2021-2032) & (US$ Million) Table 161. Netherlands α-blocker Revenue (2021-2032) & (US$ Million) Table 162. Switzerland α-blocker Revenue (2021-2032) & (US$ Million) Table 163. Sweden α-blocker Revenue (2021-2032) & (US$ Million) Table 164. Poland α-blocker Revenue (2021-2032) & (US$ Million) Table 165. China α-blocker Revenue by Type (2021-2026) & (US$ Million) Table 166. China α-blocker Revenue by Type (2027-2032) & (US$ Million) Table 167. China α-blocker Sales by Type (2021-2026) & (k tons) Table 168. China α-blocker Sales by Type (2027-2032) & (k tons) Table 169. China α-blocker Sales Price by Type (2021-2026) & (US$/ton) Table 170. China α-blocker Sales Price by Type (2027-2032) & (US$/ton) Table 171. China α-blocker Revenue by Application (2021-2026) & (US$ Million) Table 172. China α-blocker Revenue by Application (2027-2032) & (US$ Million) Table 173. China α-blocker Sales by Application (2021-2026) & (k tons) Table 174. China α-blocker Sales by Application (2027-2032) & (k tons) Table 175. China α-blocker Sales Price by Application (2021-2026) & (US$/ton) Table 176. China α-blocker Sales Price by Application (2027-2032) & (US$/ton) Table 177. Asia α-blocker Revenue by Type (2021-2026) & (US$ Million) Table 178. Asia α-blocker Revenue by Type (2027-2032) & (US$ Million) Table 179. Asia α-blocker Sales by Type (2021-2026) & (k tons) Table 180. Asia α-blocker Sales by Type (2027-2032) & (k tons) Table 181. Asia α-blocker Sales Price by Type (2021-2026) & (US$/ton) Table 182. Asia α-blocker Sales Price by Type (2027-2032) & (US$/ton) Table 183. Asia α-blocker Revenue by Application (2021-2026) & (US$ Million) Table 184. Asia α-blocker Revenue by Application (2027-2032) & (US$ Million) Table 185. Asia α-blocker Sales by Application (2021-2026) & (k tons) Table 186. Asia α-blocker Sales by Application (2027-2032) & (k tons) Table 187. Asia α-blocker Sales Price by Application (2021-2026) & (US$/ton) Table 188. Asia α-blocker Sales Price by Application (2027-2032) & (US$/ton) Table 189. Asia α-blocker Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 190. Asia α-blocker Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 191. Asia α-blocker Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 192. Asia α-blocker Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 193. Asia α-blocker Sales by Country (2021-2026) & (k tons) Table 194. Asia α-blocker Sales by Country (2027-2032) & (k tons) Table 195. Asia α-blocker Sales Price by Country (2021-2026) & (US$/ton) Table 196. Asia α-blocker Sales Price by Country (2027-2032) & (US$/ton) Table 197. Japan α-blocker Revenue (2021-2032) & (US$ Million) Table 198. South Korea α-blocker Revenue (2021-2032) & (US$ Million) Table 199. India α-blocker Revenue (2021-2032) & (US$ Million) Table 200. Australia α-blocker Revenue (2021-2032) & (US$ Million) Table 201. Taiwan α-blocker Revenue (2021-2032) & (US$ Million) Table 202. Southeast Asia α-blocker Revenue (2021-2032) & (US$ Million) Table 203. SAMEA α-blocker Revenue by Type (2021-2026) & (US$ Million) Table 204. SAMEA α-blocker Revenue by Type (2027-2032) & (US$ Million) Table 205. SAMEA α-blocker Sales by Type (2021-2026) & (k tons) Table 206. SAMEA α-blocker Sales by Type (2027-2032) & (k tons) Table 207. SAMEA α-blocker Sales Price by Type (2021-2026) & (US$/ton) Table 208. SAMEA α-blocker Sales Price by Type (2027-2032) & (US$/ton) Table 209. SAMEA α-blocker Revenue by Application (2021-2026) & (US$ Million) Table 210. SAMEA α-blocker Revenue by Application (2027-2032) & (US$ Million) Table 211. SAMEA α-blocker Sales by Application (2021-2026) & (k tons) Table 212. SAMEA α-blocker Sales by Application (2027-2032) & (k tons) Table 213. SAMEA α-blocker Sales Price by Application (2021-2026) & (US$/ton) Table 214. SAMEA α-blocker Sales Price by Application (2027-2032) & (US$/ton) Table 215. SAMEA α-blocker Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 216. SAMEA α-blocker Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 217. SAMEA α-blocker Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 218. SAMEA α-blocker Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 219. SAMEA α-blocker Sales by Country (2021-2026) & (k tons) Table 220. SAMEA α-blocker Sales by Country (2027-2032) & (k tons) Table 221. SAMEA α-blocker Sales Price by Country (2021-2026) & (US$/ton) Table 222. SAMEA α-blocker Sales Price by Country (2027-2032) & (US$/ton) Table 223. Brazil α-blocker Revenue (2021-2032) & (US$ Million) Table 224. Argentina α-blocker Revenue (2021-2032) & (US$ Million) Table 225. Chile α-blocker Revenue (2021-2032) & (US$ Million) Table 226. Colombia α-blocker Revenue (2021-2032) & (US$ Million) Table 227. Peru α-blocker Revenue (2021-2032) & (US$ Million) Table 228. Saudi Arabia α-blocker Revenue (2021-2032) & (US$ Million) Table 229. Israel α-blocker Revenue (2021-2032) & (US$ Million) Table 230. UAE α-blocker Revenue (2021-2032) & (US$ Million) Table 231. Turkey α-blocker Revenue (2021-2032) & (US$ Million) Table 232. Iran α-blocker Revenue (2021-2032) & (US$ Million) Table 233. Egypt α-blocker Revenue (2021-2032) & (US$ Million) Table 234. Key Raw Materials Table 235. Raw Materials Key Suppliers Table 236. α-blocker Distributors List Table 237. α-blocker Customers List Table 238. Research Programs/Design for This Report Table 239. Authors List of This Report Table 240. Secondary Sources Table 241. Primary Sources List of Figures Figure 1. α-blocker Image Figure 2. Global α-blocker Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global α-blocker Market Size Share 2021 VS 2025 VS 2032 Figure 4. Non-selective Antagonists Image Figure 5. Selective Antagonists Image Figure 6. Global α-blocker Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global α-blocker Market Size Share 2021 VS 2025 VS 2032 Figure 8. Raynaud's Disease Image Figure 9. Hypertension Image Figure 10. Erectile Dysfunction Image Figure 11. Global α-blocker Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global α-blocker Revenue (2021-2032) & (US$ Million) Figure 13. Global α-blocker Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global α-blocker Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global α-blocker Revenue Market Share by Region (2021-2032) Figure 16. Global α-blocker Sales (2021-2032) & (k tons) Figure 17. Global α-blocker Sales by Region: 2021 VS 2025 VS 2032 (k tons) Figure 18. Global α-blocker Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico α-blocker Sales YoY (2021-2032) & (k tons) Figure 20. Europe α-blocker Sales YoY (2021-2032) & (k tons) Figure 21. China α-blocker Sales YoY (2021-2032) & (k tons) Figure 22. Asia (Excluding China) α-blocker Sales YoY (2021-2032) & (k tons) Figure 23. South America, Middle East and Africa α-blocker Sales YoY (2021-2032) & (k tons) Figure 24. Global α-blocker Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global α-blocker Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global α-blocker Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global α-blocker Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global α-blocker Revenue Market Share by Type (2021-2032) Figure 30. Global α-blocker Sales by Type (2021 VS 2025 VS 2032) & (k tons) Figure 31. Global α-blocker Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global α-blocker Sales Market Share by Type (2021-2032) Figure 33. Global α-blocker Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global α-blocker Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global α-blocker Revenue Market Share by Application (2021-2032) Figure 36. Global α-blocker Sales by Application (2021 VS 2025 VS 2032) & (k tons) Figure 37. Global α-blocker Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global α-blocker Sales Market Share by Application (2021-2032) Figure 39. North America α-blocker Revenue Share by Type (2021-2032) Figure 40. North America α-blocker Sales Share by Type (2021-2032) Figure 41. North America α-blocker Revenue Share by Application (2021-2032) Figure 42. North America α-blocker Sales Share by Application (2021-2032) Figure 43. North America α-blocker Revenue Share by Country (2021-2032) Figure 44. North America α-blocker Sales Share by Country (2021-2032) Figure 45. Europe α-blocker Revenue Share by Type (2021-2032) Figure 46. Europe α-blocker Sales Share by Type (2021-2032) Figure 47. Europe α-blocker Revenue Share by Application (2021-2032) Figure 48. Europe α-blocker Sales Share by Application (2021-2032) Figure 49. Europe α-blocker Revenue Share by Country (2021-2032) Figure 50. Europe α-blocker Sales Share by Country (2021-2032) Figure 51. China α-blocker Revenue Share by Type (2021-2032) Figure 52. China α-blocker Sales Share by Type (2021-2032) Figure 53. China α-blocker Revenue Share by Application (2021-2032) Figure 54. China α-blocker Sales Share by Application (2021-2032) Figure 55. Asia α-blocker Revenue Share by Type (2021-2032) Figure 56. Asia α-blocker Sales Share by Type (2021-2032) Figure 57. Asia α-blocker Revenue Share by Application (2021-2032) Figure 58. Asia α-blocker Sales Share by Application (2021-2032) Figure 59. Asia α-blocker Revenue Share by Country (2021-2032) Figure 60. Asia α-blocker Sales Share by Country (2021-2032) Figure 61. SAMEA α-blocker Revenue Share by Type (2021-2032) Figure 62. SAMEA α-blocker Sales Share by Type (2021-2032) Figure 63. SAMEA α-blocker Revenue Share by Application (2021-2032) Figure 64. SAMEA α-blocker Sales Share by Application (2021-2032) Figure 65. SAMEA α-blocker Revenue Share by Country (2021-2032) Figure 66. SAMEA α-blocker Sales Share by Country (2021-2032) Figure 67. α-blocker Value Chain Figure 68. Manufacturing Cost Structure Figure 69. α-blocker Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Non-selective Antagonists
  • Selective Antagonists
Applications
  • Raynaud's Disease
  • Hypertension
  • Erectile Dysfunction
Companies covered
  • Teva Pharmaceutical
  • Sanofi
  • Jhonson and Johnson
  • Novartis
  • Merck
  • Eli Lilly
  • Pfizer
  • GSK
  • Bayer
  • Bristol-Myers Squibb
  • Astra Zeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 α-blocker Market by Type
  3. 1.2.1 Global α-blocker Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Non-selective Antagonists
  5. 1.2.3 Selective Antagonists
  6. 1.3 α-blocker Market by Application
  7. 1.3.1 Global α-blocker Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Raynaud's Disease
  9. 1.3.3 Hypertension
  10. 1.3.4 Erectile Dysfunction
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 α-blocker Market Dynamics
  1. 2.1 α-blocker Industry Trends
  2. 2.2 α-blocker Industry Drivers
  3. 2.3 α-blocker Industry Opportunities and Challenges
  4. 2.4 α-blocker Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global α-blocker Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global α-blocker Revenue by Region
  3. 3.2.1 Global α-blocker Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global α-blocker Revenue by Region (2021-2026)
  5. 3.2.3 Global α-blocker Revenue by Region (2027-2032)
  6. 3.2.4 Global α-blocker Revenue Market Share by Region (2021-2032)
  7. 3.3 Global α-blocker Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global α-blocker Sales by Region
  9. 3.4.1 Global α-blocker Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global α-blocker Sales by Region (2021-2026)
  11. 3.4.3 Global α-blocker Sales by Region (2027-2032)
  12. 3.4.4 Global α-blocker Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global α-blocker Revenue by Manufacturers
  2. 4.1.1 Global α-blocker Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global α-blocker Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global α-blocker Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global α-blocker Sales by Manufacturers
  6. 4.2.1 Global α-blocker Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global α-blocker Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global α-blocker Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global α-blocker Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global α-blocker Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global α-blocker Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global α-blocker Manufacturers, Product Type & Application
  13. 4.7 Global α-blocker Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global α-blocker Market CR5 and HHI
  16. 4.8.2 2025 α-blocker Tier 1, Tier 2, and Tier 3
5 α-blocker Market by Type
  1. 5.1 Global α-blocker Revenue by Type
  2. 5.1.1 Global α-blocker Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global α-blocker Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global α-blocker Revenue Market Share by Type (2021-2032)
  5. 5.2 Global α-blocker Sales by Type
  6. 5.2.1 Global α-blocker Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global α-blocker Sales by Type (2021-2032) & (k tons)
  8. 5.2.3 Global α-blocker Sales Market Share by Type (2021-2032)
  9. 5.3 Global α-blocker Price by Type
6 α-blocker Market by Application
  1. 6.1 Global α-blocker Revenue by Application
  2. 6.1.1 Global α-blocker Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global α-blocker Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global α-blocker Revenue Market Share by Application (2021-2032)
  5. 6.2 Global α-blocker Sales by Application
  6. 6.2.1 Global α-blocker Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global α-blocker Sales by Application (2021-2032) & (k tons)
  8. 6.2.3 Global α-blocker Sales Market Share by Application (2021-2032)
  9. 6.3 Global α-blocker Price by Application
7 Company Profiles
  1. 7.1 Teva Pharmaceutical
  2. 7.1.1 Teva Pharmaceutical Company Information
  3. 7.1.2 Teva Pharmaceutical Business Overview
  4. 7.1.3 Teva Pharmaceutical α-blocker Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Teva Pharmaceutical α-blocker Product Portfolio
  6. 7.1.5 Teva Pharmaceutical Recent Developments
  7. 7.2 Sanofi
  8. 7.2.1 Sanofi Company Information
  9. 7.2.2 Sanofi Business Overview
  10. 7.2.3 Sanofi α-blocker Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sanofi α-blocker Product Portfolio
  12. 7.2.5 Sanofi Recent Developments
  13. 7.3 Jhonson and Johnson
  14. 7.3.1 Jhonson and Johnson Company Information
  15. 7.3.2 Jhonson and Johnson Business Overview
  16. 7.3.3 Jhonson and Johnson α-blocker Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Jhonson and Johnson α-blocker Product Portfolio
  18. 7.3.5 Jhonson and Johnson Recent Developments
  19. 7.4 Novartis
  20. 7.4.1 Novartis Company Information
  21. 7.4.2 Novartis Business Overview
  22. 7.4.3 Novartis α-blocker Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Novartis α-blocker Product Portfolio
  24. 7.4.5 Novartis Recent Developments
  25. 7.5 Merck
  26. 7.5.1 Merck Company Information
  27. 7.5.2 Merck Business Overview
  28. 7.5.3 Merck α-blocker Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Merck α-blocker Product Portfolio
  30. 7.5.5 Merck Recent Developments
  31. 7.6 Eli Lilly
  32. 7.6.1 Eli Lilly Company Information
  33. 7.6.2 Eli Lilly Business Overview
  34. 7.6.3 Eli Lilly α-blocker Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Eli Lilly α-blocker Product Portfolio
  36. 7.6.5 Eli Lilly Recent Developments
  37. 7.7 Pfizer
  38. 7.7.1 Pfizer Company Information
  39. 7.7.2 Pfizer Business Overview
  40. 7.7.3 Pfizer α-blocker Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Pfizer α-blocker Product Portfolio
  42. 7.7.5 Pfizer Recent Developments
  43. 7.8 GSK
  44. 7.8.1 GSK Company Information
  45. 7.8.2 GSK Business Overview
  46. 7.8.3 GSK α-blocker Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 GSK α-blocker Product Portfolio
  48. 7.8.5 GSK Recent Developments
  49. 7.9 Bayer
  50. 7.9.1 Bayer Company Information
  51. 7.9.2 Bayer Business Overview
  52. 7.9.3 Bayer α-blocker Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Bayer α-blocker Product Portfolio
  54. 7.9.5 Bayer Recent Developments
  55. 7.10 Bristol-Myers Squibb
  56. 7.10.1 Bristol-Myers Squibb Company Information
  57. 7.10.2 Bristol-Myers Squibb Business Overview
  58. 7.10.3 Bristol-Myers Squibb α-blocker Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Bristol-Myers Squibb α-blocker Product Portfolio
  60. 7.10.5 Bristol-Myers Squibb Recent Developments
  61. 7.11 Astra Zeneca
  62. 7.11.1 Astra Zeneca Company Information
  63. 7.11.2 Astra Zeneca Business Overview
  64. 7.11.3 Astra Zeneca α-blocker Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Astra Zeneca α-blocker Product Portfolio
  66. 7.11.5 Astra Zeneca Recent Developments
8 North America
  1. 8.1 North America α-blocker Market Size by Type
  2. 8.1.1 North America α-blocker Revenue by Type (2021-2032)
  3. 8.1.2 North America α-blocker Sales by Type (2021-2032)
  4. 8.1.3 North America α-blocker Price by Type (2021-2032)
  5. 8.2 North America α-blocker Market Size by Application
  6. 8.2.1 North America α-blocker Revenue by Application (2021-2032)
  7. 8.2.2 North America α-blocker Sales by Application (2021-2032)
  8. 8.2.3 North America α-blocker Price by Application (2021-2032)
  9. 8.3 North America α-blocker Market Size by Country
  10. 8.3.1 North America α-blocker Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America α-blocker Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America α-blocker Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe α-blocker Market Size by Type
  2. 9.1.1 Europe α-blocker Revenue by Type (2021-2032)
  3. 9.1.2 Europe α-blocker Sales by Type (2021-2032)
  4. 9.1.3 Europe α-blocker Price by Type (2021-2032)
  5. 9.2 Europe α-blocker Market Size by Application
  6. 9.2.1 Europe α-blocker Revenue by Application (2021-2032)
  7. 9.2.2 Europe α-blocker Sales by Application (2021-2032)
  8. 9.2.3 Europe α-blocker Price by Application (2021-2032)
  9. 9.3 Europe α-blocker Market Size by Country
  10. 9.3.1 Europe α-blocker Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe α-blocker Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe α-blocker Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China α-blocker Market Size by Type
  2. 10.1.1 China α-blocker Revenue by Type (2021-2032)
  3. 10.1.2 China α-blocker Sales by Type (2021-2032)
  4. 10.1.3 China α-blocker Price by Type (2021-2032)
  5. 10.2 China α-blocker Market Size by Application
  6. 10.2.1 China α-blocker Revenue by Application (2021-2032)
  7. 10.2.2 China α-blocker Sales by Application (2021-2032)
  8. 10.2.3 China α-blocker Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia α-blocker Market Size by Type
  2. 11.1.1 Asia α-blocker Revenue by Type (2021-2032)
  3. 11.1.2 Asia α-blocker Sales by Type (2021-2032)
  4. 11.1.3 Asia α-blocker Price by Type (2021-2032)
  5. 11.2 Asia α-blocker Market Size by Application
  6. 11.2.1 Asia α-blocker Revenue by Application (2021-2032)
  7. 11.2.2 Asia α-blocker Sales by Application (2021-2032)
  8. 11.2.3 Asia α-blocker Price by Application (2021-2032)
  9. 11.3 Asia α-blocker Market Size by Country
  10. 11.3.1 Asia α-blocker Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia α-blocker Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia α-blocker Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA α-blocker Market Size by Type
  2. 12.1.1 SAMEA α-blocker Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA α-blocker Sales by Type (2021-2032)
  4. 12.1.3 SAMEA α-blocker Price by Type (2021-2032)
  5. 12.2 SAMEA α-blocker Market Size by Application
  6. 12.2.1 SAMEA α-blocker Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA α-blocker Sales by Application (2021-2032)
  8. 12.2.3 SAMEA α-blocker Price by Application (2021-2032)
  9. 12.3 SAMEA α-blocker Market Size by Country
  10. 12.3.1 SAMEA α-blocker Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA α-blocker Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA α-blocker Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 α-blocker Value Chain Analysis
  2. 13.1.1 α-blocker Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 α-blocker Production Mode & Process
  6. 13.2 α-blocker Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 α-blocker Distributors
  9. 13.2.3 α-blocker Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst